Chemotherapy induced Takotsubo cardiomyopathy
Related Experiment Video
Updated: Apr 22, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Sunny Goel1, Abhishek Sharma1, Aakash Garg1
1Sunny Goel, Abhishek Sharma, Abhinav Chandra, Vijay Shetty, Department of Medicine, Maimonides Medical Center, Brooklyn, NY 11219, United States.
Abstract:
Chemotherapy has been linked with Takotsubo cardiomyopathy. Most of the literature on chemotherapy associated Takotsubo cardiomyopathy is on the drug 5-fluorouracil. In this report, we describe the case of a 55-year-old Asian male who developed Takotsubo cardiomyopathy while receiving dual chemotherapy with cytarabine and daunorubicin for acute myeloid leukemia. To our knowledge, it is the first case of Takotsubo cardiomyopathy associated with daunorubicin and/or cytarabine.
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy I: Introduction and Classification
Heart Failure Drugs: Inotropic Agents
Myocarditis IV: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

